Zongertinib to Target HER2-Driven Resistance in EGFR Mutation-Positive NSCLC: A Case Report

  1. Torres-Jiménez,J.
  2. Serrano-Gómez,C.
  3. Baena-Espinar,J.
  4. de Cabo,H.B.
  5. Zurera-Berjaga,M.
  6. López-Martín,A.
  7. Ponce-Aix,S.
  8. Paz-Ares,L.
  9. Zugazagoitia,J.
Journal:
Clinical Lung Cancer

ISSN: 1938-0690,  1525-7304

Year of publication: 2026

Volume: 27

Issue: 8

Pages: 50-53

Type: Article

DOI: 10.1016/J.CLLC.2026.08.010 GOOGLE SCHOLAR lock_openOpen access editor